압타머 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)
Aptamer Market (Material: Nucleic Acid Aptamer and Peptide Aptamer; and Technique: SELEX Technique and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
상품코드:1402894
리서치사:Transparency Market Research
발행일:2023년 11월
페이지 정보:영문 170 Pages
라이선스 & 가격 (부가세 별도)
한글목차
압타머 시장 - 보고서의 범위
세계 압타머 시장에 대한 TMR의 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 2023년을 기준 연도, 2031년을 예측 연도로 간주하여 2017년부터 2031년까지의 기간 동안 세계 압타머 시장의 수익을 제공합니다. 이 보고서는 또한 2023년부터 2031년까지 세계 압타머 시장의 복합 연간 성장률(CAGR%)을 제공합니다.
이 보고서는 광범위한 조사를 통해 작성되었습니다. KOL(Key Opinion Leader), 업계 리더 및 제조업체를 인터뷰하는 1차 조사 활동의 대부분을 분석가들이 수행했으며, 2차 조사에는 압타머 시장을 이해하기 위해 주요 업체의 제품 문헌, 연례 보고서, 보도 자료 및 관련 문서 참조가 포함되었습니다.
시장 현황
2023년 시장 가치
17억 달러
2031년 시장 가치
70억 달러
CAGR
16.5%
이 보고서는 세계 압타머 시장 경쟁 구도에 대해 자세히 분석합니다. 세계 압타머 시장에서 활동하는 주요 기업이 확인되며, 이들 각각은 다양한 속성 측면에서 프로파일링됩니다. 기업 프로파일, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 압타머 시장 기업의 속성입니다.
목차
제1장 주요 요약
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
시장 세분화
개요
시장 역학
세계 시장 분석과 예측, 2023-2031년
제5장 주요 인사이트
파이프라인 분석
COVID-19 팬데믹이 업계에 미치는 영향
제6장 시장 분석과 예측 : 재료별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 재료별, 2023-2031
핵산
펩티드
시장의 매력 : 재료별
제7장 시장 분석과 예측 : 용도별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 용도별, 2023-2031
연구
진단
치료
기타
시장의 매력 : 용도별
제8장 세계 시장 분석과 예측 : 방법별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 방법별, 2023-2031
세렉스법
기타(MARAS 등)
시장의 매력 : 방법별
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2023-2031
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제10장 북미 시장 분석과 예측
제11장 유럽 시장 분석과 예측
제12장 아시아태평양 시장 분석과 예측
제13장 라틴아메리카 시장 분석과 예측
제14장 중동 및 아프리카 시장 분석과 예측
제15장 경쟁 구도
시장 기업--경쟁 매트릭스(기업 Tier 및 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
AM Biotech
Aptagen, LLC
Group
Science, Inc.
Pfizer Inc.
Base Pair Biotechnologies
CD Genomics
NeoVentures Biotechnology Inc.
NAXXON Pharma
Aptus Biotech
TriLink Bio Technologies, LLC
LSH
영문 목차
영문목차
Aptamer Market - Scope of Report
TMR's report on the global aptamer market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global aptamer market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global aptamer market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the aptamer market.
Market Snapshot
Market Value in 2023
US$ 1.7 Bn
Market Value in 2031
US$ 7 Bn
CAGR
16.5%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global aptamer market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global aptamer market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global aptamer market.
The report delves into the competitive landscape of the global aptamer market. Key players operating in the global aptamer market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global aptamer market profiled in this report.
Key Questions Answered in Global aptamer Market Report:
What is the sales/revenue generated by aptamer across all regions during the forecast period?
What are the opportunities in the global aptamer market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Aptamer Market - Research Objectives and Research Approach
The comprehensive report on the global aptamer market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global aptamer market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global aptamer market.
Table of Contents
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Aptamer Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Aptamer Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. COVID-19 Pandemic Impact on Industry
6. Aptamer Market Analysis and Forecast, by Material
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Material, 2023-2031
6.3.1. Nucleic Acid Aptamer
6.3.2. Peptide Aptamer
6.4. Market Attractiveness, by Material
7. Aptamer Market Analysis and Forecast, by Application
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2023-2031
7.3.1. Research
7.3.2. Diagnostic
7.3.3. Therapeutics
7.3.4. Others
7.3.5. 7.4 Market Attractiveness, by Application
8. Global Aptamer Market Analysis and Forecast, by Technique
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Technique, 2023-2031
8.3.1. SELEX Technique
8.3.2. Others (MARAS, etc.)
8.4. Market Attractiveness, by Technique
9. Global Aptamer Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2023-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Aptamer Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Material, 2023-2031
10.2.1. Nucleic Acid Aptamer
10.2.2. Peptide Aptamer
10.3. Market Attractiveness, by Material
10.4. Market Value Forecast, by Application, 2023-2031
10.4.1. Research
10.4.2. Diagnostic
10.4.3. Therapeutics
10.4.4. Others
10.5. Market Attractiveness, by Application
10.6. Market Value Forecast, by Technique, 2023-2031
10.6.1. SELEX Technique
10.6.2. Others (MARAS, etc.)
10.7. Market Attractiveness, by Technique
10.8. Market Value Forecast, by Country, 2022-2031
10.8.1. U.S.
10.8.2. Canada
10.9. Market Attractiveness Analysis
10.9.1. By Material
10.9.2. By Application
10.9.3. By Technique
10.9.4. By Country
11. Europe Aptamer Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Material, 2023-2031
11.2.1. Nucleic Acid Aptamer
11.2.2. Peptide Aptamer
11.3. Market Attractiveness, by Material
11.4. Market Value Forecast, by Application, 2023-2031
11.4.1. Research
11.4.2. Diagnostic
11.4.3. Therapeutics
11.4.4. Others
11.5. Market Attractiveness, by Application
11.6. Market Value Forecast, by Technique, 2023-2031
11.6.1. SELEX Technique
11.6.2. Others (MARAS, etc.)
11.7. Market Attractiveness, by Technique
11.8. Market Value Forecast, by Country/Sub-region, 2022-2031
11.8.1. Germany
11.8.2. U.K.
11.8.3. France
11.8.4. Italy
11.8.5. Spain
11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
11.9.1. By Material
11.9.2. By Application
11.9.3. By Technique
11.9.4. By Country/Sub-region
12. Asia Pacific Aptamer Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Material, 2023-2031
12.2.1. Nucleic Acid Aptamer
12.2.2. Peptide Aptamer
12.3. Market Attractiveness, by Material
12.4. Market Value Forecast, by Application, 2023-2031
12.4.1. Research
12.4.2. Diagnostic
12.4.3. Therapeutics
12.4.4. Others
12.5. Market Attractiveness, by Application
12.6. Market Value Forecast, by Technique, 2023-2031
12.6.1. SELEX Technique
12.6.2. Others (MARAS, etc.)
12.7. Market Attractiveness, by Technique
12.8. Market Value Forecast, by Country/Sub-region, 2023-2031
12.8.1. China
12.8.2. Japan
12.8.3. India
12.8.4. Australia & New Zealand
12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
12.9.1. By Material
12.9.2. By Application
12.9.3. By Technique
12.9.4. By Country/Sub-region
13. Latin America Aptamer Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Material, 2023-2031
13.2.1. Nucleic Acid Aptamer
13.2.2. Peptide Aptamer
13.3. Market Attractiveness, by Material
13.4. Market Value Forecast, by Application, 2023-2031
13.4.1. Research
13.4.2. Diagnostic
13.4.3. Therapeutics
13.4.4. Others
13.5. Market Attractiveness, by Application
13.6. Market Value Forecast, by Technique, 2023-2031
13.6.1. SELEX Technique
13.6.2. Others (MARAS, etc.)
13.7. Market Attractiveness, by Technique
13.8. Market Value Forecast, by Country/Sub-region, 2023-2031
13.8.1. Brazil
13.8.2. Mexico
13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
13.9.1. By Material
13.9.2. By Application
13.9.3. By Technique
13.9.4. By Country/Sub-region
14. Middle East & Africa Aptamer Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Material, 2023-2031
14.2.1. Nucleic Acid Aptamer
14.2.2. Peptide Aptamer
14.3. Market Attractiveness, by Material
14.4. Market Value Forecast, by Application, 2023-2031
14.4.1. Research
14.4.2. Diagnostic
14.4.3. Therapeutics
14.4.4. Others
14.5. Market Attractiveness, by Application
14.6. Market Value Forecast, by Technique, 2023-2031
14.6.1. SELEX Technique
14.6.2. Others (MARAS, etc.)
14.7. Market Attractiveness, by Technique
14.8. Market Value Forecast, by Country/Sub-region, 2023-2031
14.8.1. GCC Countries
14.8.2. South Africa
14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
14.9.1. By Material
14.9.2. By Application
14.9.3. By Technique
14.9.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. AM Biotech
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Aptagen, LLC
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Aptamer Group
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Aptamer Science, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Pfizer Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Base Pair Biotechnologies
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. CD Genomics
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. NeoVentures Biotechnology Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. NAXXON Pharma
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. Aptus Biotech
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. TriLink Bio Technologies, LLC
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
